Insight Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Insight Advisors's BMY Position: Q3 2025 in Review
Insight Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 4,592 shares — an estimated $213K sold.
Insight Advisors first reported a position in BMY in Q4 2020 and held it in 18 quarters. The position peaked at $513K in Q1 2021. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Insight Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
- Insight Advisors sold 4,592 Bristol-Myers Squibb shares in Q3 2025, an estimated $213K.
- Insight Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 18 quarters.
- Insight Advisors's Bristol-Myers Squibb position peaked at $513K in Q1 2021.
- 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Insight Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.